##gff-version 3
##sequence-region Q86YP4 1 633
Q86YP4	UniProtKB	Chain	1	633	.	.	.	ID=PRO_0000083500;Note=Transcriptional repressor p66-alpha	
Q86YP4	UniProtKB	Zinc finger	411	464	.	.	.	Note=GATA-type;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00094	
Q86YP4	UniProtKB	Region	144	178	.	.	.	Note=CR1%3B MBD2-binding	
Q86YP4	UniProtKB	Region	340	480	.	.	.	Note=CR2%3B histone tail-binding	
Q86YP4	UniProtKB	Coiled coil	139	174	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YP4	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q86YP4	UniProtKB	Modified residue	49	49	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18220336,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:18220336,PMID:18669648,PMID:19690332,PMID:20068231,PMID:21406692,PMID:23186163,PMID:24275569	
Q86YP4	UniProtKB	Modified residue	100	100	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:16964243,ECO:0000244|PubMed:18220336,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:16964243,PMID:18220336,PMID:18669648,PMID:19690332,PMID:20068231,PMID:21406692,PMID:23186163,PMID:24275569	
Q86YP4	UniProtKB	Modified residue	107	107	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:16964243,ECO:0000244|PubMed:18220336,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:16964243,PMID:18220336,PMID:18669648,PMID:19690332,PMID:20068231,PMID:21406692,PMID:23186163,PMID:24275569	
Q86YP4	UniProtKB	Modified residue	113	113	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q8CHY6	
Q86YP4	UniProtKB	Modified residue	114	114	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:16964243,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:23186163;Dbxref=PMID:16964243,PMID:18669648,PMID:19690332,PMID:23186163	
Q86YP4	UniProtKB	Modified residue	137	137	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q86YP4	UniProtKB	Modified residue	189	189	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:19690332,PMID:23186163,PMID:24275569	
Q86YP4	UniProtKB	Modified residue	225	225	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q8CHY6	
Q86YP4	UniProtKB	Modified residue	249	249	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q86YP4	UniProtKB	Modified residue	258	258	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q86YP4	UniProtKB	Modified residue	273	273	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q86YP4	UniProtKB	Modified residue	275	275	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q86YP4	UniProtKB	Modified residue	285	285	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q86YP4	UniProtKB	Modified residue	340	340	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:23186163;Dbxref=PMID:19690332,PMID:23186163	
Q86YP4	UniProtKB	Modified residue	343	343	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:21406692;Dbxref=PMID:21406692	
Q86YP4	UniProtKB	Modified residue	512	512	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q86YP4	UniProtKB	Modified residue	539	539	.	.	.	Note=Asymmetric dimethylarginine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q86YP4	UniProtKB	Modified residue	539	539	.	.	.	Note=Omega-N-methylarginine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q86YP4	UniProtKB	Modified residue	546	546	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:20068231,PMID:23186163	
Q86YP4	UniProtKB	Modified residue	548	548	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:20068231,PMID:23186163	
Q86YP4	UniProtKB	Modified residue	556	556	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q86YP4	UniProtKB	Modified residue	598	598	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
Q86YP4	UniProtKB	Cross-link	93	93	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q86YP4	UniProtKB	Cross-link	178	178	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q86YP4	UniProtKB	Cross-link	204	204	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q86YP4	UniProtKB	Cross-link	233	233	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q86YP4	UniProtKB	Cross-link	464	464	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q86YP4	UniProtKB	Cross-link	487	487	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:25755297,PMID:25772364,PMID:28112733	
Q86YP4	UniProtKB	Cross-link	550	550	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:25772364,PMID:28112733	
Q86YP4	UniProtKB	Cross-link	585	585	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q86YP4	UniProtKB	Cross-link	605	605	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q86YP4	UniProtKB	Alternative sequence	401	401	.	.	.	ID=VSP_053410;Note=In isoform 3. Q->QA;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q86YP4	UniProtKB	Alternative sequence	500	524	.	.	.	ID=VSP_010929;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:17974005;Dbxref=PMID:17974005	
Q86YP4	UniProtKB	Natural variant	17	17	.	.	.	ID=VAR_059308;Note=R->Q;Dbxref=dbSNP:rs10426883	
Q86YP4	UniProtKB	Natural variant	296	296	.	.	.	ID=VAR_059309;Note=N->S;Dbxref=dbSNP:rs2288851	
Q86YP4	UniProtKB	Mutagenesis	149	149	.	.	.	Note=Disruption of MBD2-binding%2C loss of enhancement of MBD2-mediated repression and loss of speckled nuclear localization. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16415179;Dbxref=PMID:16415179	
Q86YP4	UniProtKB	Sequence conflict	432	432	.	.	.	Note=K->E;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q86YP4	UniProtKB	Helix	138	168	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2L2L	
